Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation

Diabetic Medicine

Volumn 25, Issue 3, 2008, Pages 277-281

  Slingerland, A S ^a,b,g   Hurkx, W ^c   Noordam, K ^d   Flanagan, S E ^a   Jukema, J W ^b   Meiners, L C ^e   Bruining, G J ^f   Hattersley, A T ^a   Hadders Algra, M ^e  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ELKERLIEK HOSPITAL   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MÁXIMA MEDICAL CENTER   (Netherlands)

^g NONE   (Netherlands)

Author keywords

Brain; KCNJ11; Kir6.2; Sulphonylurea; V59M

Indexed keywords

C REACTIVE PROTEIN; GLIBENCLAMIDE; INSULIN; SULFONYLUREA;

ADOLESCENT; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DOSE REDUCTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERGLYCEMIA; LOW BIRTH WEIGHT; MALE; MENTAL FUNCTION; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

BRAIN; COGNITION; DEVELOPMENTAL DISABILITIES; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; MALE; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SULFONYLUREA COMPOUNDS;

EID: 40049100688     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02373.x     Document Type: Article

References (18)

1. Gloyn AL, Pearson ER, Antcliff JF, Proks PG, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004 350 : 1838 1849.
2. Slingerland AS, Hattersley AT. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 2005 37 : 186 195.
3. Hattersley AT, Ashcroft FM. Activating mutations in kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005 54 : 2503 2513.
4. Pearson ER, Flechtner I, Njolstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006 355 : 467 477.
5. Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia 2006 49 : 2559 2563.
6. Bayley N. Bayley Scales of Infant Development. New York : The Psychological Corporation, 1969.
7. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006 49 : 1190 1197.
8. Flykanaka-Gantenbein C. Hypoglycemia in childhood: long-term effects. Pediatr Endocrinol Rev 2004 1 (Suppl. 3 530 536.
9. Flechtner I, de Lonlay P, Polak M. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences. Diabetes Metab 2006 32 : 569 580.
10. Ryan CM, Dulay D, Suprasongsin C, Becker DJ. Detection of symptoms by adolescents and young adults with type 1 diabetes during experimental induction of mild hypoglycemia: role of hormonal and psychological variables. Diabetes Care 2002 25 : 852 858.
11. Warren RE, Zammitt NN, Deary IJ, Frier BM. The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes. Diabetologia 2007 50 : 178 185.
12. Strachan MW. Insulin and cognitive function in humans: experimental data and therapeutic considerations. Biochem Soc Trans 2005 33 : 1037 1040.
13. Strachan MW. Insulin and cognitive function. Lancet 2003 362 : 1253.
14. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 2004 101 : 17539 17544.
15. Tammaro P, Girard C, Molnes J, Njolstad PR, Ashcroft FM. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions. EMBO J 2005 24 : 2318 2330.
16. Kostovic I, Judas M. Prolonged coexistence of transient and permanent circuitry elements in the developing cerebral cortex of fetuses and preterm infants. Dev Med Child Neurol. 2006 48 : 388 393.
17. Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006 29 : 345 351.
18. de Graaf-Peters VB, Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when? Early Hum Dev. 2006 82 : 257 266.